C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck
Authors:
- Scott A. KoepsellSKScott A. Koepsell
- Stefano R. TarantoloSTStefano R. Tarantolo
- 12 September 2005
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 27 (10) , 883-892
Abstract
Background. Synovial sarcoma is a malignant mesenchymal tumor composed of varying proportions of spindle and epithelial cell components. Because of the histologic and immunohistochemical similarity of synovial sarcoma to epithelial carcinomas, we hypothesized that the human epithelial growth factor receptor 2 (C‐erb‐B2, also termed HER2/neu) may contribute to the tumor phenotype and provide a new therapeutic target for this soft tissue tumor. Methods. Three head and neck, one chest wall, and seven extremity synovial sarcomas were evaluated for C‐erb‐B2 (HER2/neu) expression by immunohistochemistry, Western immunoblotting, and fluorescence in situ hybridization (FISH). Results. The head and neck cases demonstrated immunohistochemically strong positive staining, whereas tumors from other anatomic locations showed neither positive nor cytoplasmic restricted staining. Antigen‐targeted antibody therapy (trastuzumab) was initiated in two patients. Conclusions. These results demonstrate that C‐erb‐B2 (HER2/neu) may play a role in the tumorigenesis of synovial sarcoma; and, therefore, antigrowth factor therapies may provide a previously unrecognized pharmaceutical approach to soft tissue tumors. The data also suggest that although synovial sarcoma of the head and neck and synovial sarcoma of the extremities have similar morphologic features, they may be clinically and mechanistically distinct entities. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005Keywords
This publication has 37 references indexed in Scilit:
- Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasEuropean Journal of Cancer, 2004
- Molecular characterisation of soft tissue tumours: a gene expression studyThe Lancet, 2002
- Molecular Approaches to Sarcoma TherapySarcoma, 2002
- Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteinsOncogene, 2001
- Prognostic Significance of Apoptosis in Synovial Sarcoma: Correlation with Clinicopathologic Parameters, Cell Proliferative Activity, and Expression of Apoptosis-Related ProteinsLaboratory Investigation, 2000
- The Quality of Her-2/Neu Predictive Immunohistochemistry: Something FISHy?Laboratory Investigation, 2000
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- Head and neck synovial sarcomasJournal of Surgical Oncology, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985